• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国广西接受抗逆转录病毒疗法的艾滋病毒/艾滋病个体中二次艾滋病毒传播的趋势、流行率和潜在危险因素:一项纵向横断面研究。

The trend, prevalence and potential risk factors of secondary HIV transmission among HIV/AIDS individuals receiving ART in Guangxi, China: a longitudinal cross-sectional study.

机构信息

Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.

Guangxi Engineering Center for Organoids and Organ-on-chips of Highly Pathogenic Microbial Infections & Biosafety III laboratory, Life Science Institute, Guangxi Medical University, Nanning, People's Republic of China.

出版信息

Emerg Microbes Infect. 2024 Dec;13(1):2429622. doi: 10.1080/22221751.2024.2429622. Epub 2024 Nov 23.

DOI:10.1080/22221751.2024.2429622
PMID:39552513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11587721/
Abstract

Identifying the prevalence and risk factors of secondary human immunodeficiency virus (HIV) transmission from people living with HIV (PLWH) to other people is crucial for ending the HIV epidemic. However, the data among antiretroviral therapy (ART) patients is limited. This study aims to assess the prevalence and risk factors of secondary HIV transmission among PLWH receiving ART by longitudinal molecular networks in China. In this study, the prevalence of secondary HIV transmission was 10.8%. The R was greater than 1 from 2017 to 2021 and peaked in 2019. PLWHs who were male sex, older age, engaged in condomless sex, experienced higher ART follow-up viral load, experienced ART medical omissions, infected with non-CRF01_AE subtype, and self-reported sexually transmitted infections (STIs) at HIV diagnosis increased the risk of secondary HIV transmission. However, those participants with higher education were less likely to be involved in secondary HIV transmission. The diagnostic age of the participants was nonlinearly associated with the risk of secondary HIV transmission, with a cutoff value of 43.13 years indicating a higher risk of secondary HIV transmission for patients diagnosed at or above this age. This study revealed substantial secondary HIV transmission and persistent HIV expansion among local PLWH, highlighting the necessity of enhancing viral load monitor, promoting adherence to ART, and promoting safe sex practices, particularly among older adults with HIV, to mitigate secondary HIV transmission.

摘要

确定接受抗逆转录病毒疗法 (ART) 的艾滋病毒感染者 (PLWH) 向其他人传播继发性 HIV 的流行率和风险因素对于终结 HIV 流行至关重要。然而,ART 患者的数据有限。本研究旨在通过中国纵向分子网络评估接受 ART 的 PLWH 中继发性 HIV 传播的流行率和风险因素。

在这项研究中,继发性 HIV 传播的流行率为 10.8%。2017 年至 2021 年,R 值大于 1,并在 2019 年达到峰值。男性、年龄较大、无保护性行为、ART 随访病毒载量较高、ART 医疗疏漏、感染非 CRF01_AE 亚型以及 HIV 诊断时自我报告性传播感染 (STI) 的 PLWH 增加了继发性 HIV 传播的风险。然而,受教育程度较高的参与者不太可能参与继发性 HIV 传播。参与者的诊断年龄与继发性 HIV 传播的风险呈非线性相关,诊断年龄为 43.13 岁或以上的患者具有更高的继发性 HIV 传播风险。

本研究揭示了本地 PLWH 中存在大量继发性 HIV 传播和持续的 HIV 扩张,这强调了加强病毒载量监测、促进 ART 依从性以及促进安全性行为的必要性,特别是对于年龄较大的 HIV 感染者,以减轻继发性 HIV 传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/85d8d04e1725/TEMI_A_2429622_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/879ac635444a/TEMI_A_2429622_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/dcf830b98334/TEMI_A_2429622_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/b0e9a7295bdf/TEMI_A_2429622_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/85d8d04e1725/TEMI_A_2429622_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/879ac635444a/TEMI_A_2429622_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/dcf830b98334/TEMI_A_2429622_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/b0e9a7295bdf/TEMI_A_2429622_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eee/11587721/85d8d04e1725/TEMI_A_2429622_F0004_OC.jpg

相似文献

1
The trend, prevalence and potential risk factors of secondary HIV transmission among HIV/AIDS individuals receiving ART in Guangxi, China: a longitudinal cross-sectional study.中国广西接受抗逆转录病毒疗法的艾滋病毒/艾滋病个体中二次艾滋病毒传播的趋势、流行率和潜在危险因素:一项纵向横断面研究。
Emerg Microbes Infect. 2024 Dec;13(1):2429622. doi: 10.1080/22221751.2024.2429622. Epub 2024 Nov 23.
2
Low CD4 count was characterized in recent HIV CRF01_AE infection and it rapidly increased to reach a peak in the first year since ART initiation.低CD4细胞计数是近期HIV CRF01_AE感染的特征,并且在开始抗逆转录病毒治疗后的第一年迅速上升至峰值。
BMC Infect Dis. 2025 Mar 31;25(1):443. doi: 10.1186/s12879-025-10799-5.
3
Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.中国广西接受抗逆转录病毒治疗的HIV-1感染者的耐药性及其影响因素
J Antimicrob Chemother. 2024 May 2;79(5):1142-1152. doi: 10.1093/jac/dkae084.
4
Current syphilis infection in virally suppressed people living with HIV: a cross-sectional study in eastern China.中国东部一项横断面研究:病毒抑制的 HIV 感染者现患梅毒感染。
Front Public Health. 2024 Jun 19;12:1366795. doi: 10.3389/fpubh.2024.1366795. eCollection 2024.
5
Sexual behaviour among people with HIV according to self-reported antiretroviral treatment and viral load status.根据自我报告的抗逆转录病毒治疗情况和病毒载量状态,分析HIV感染者的性行为。
AIDS. 2016 Jul 17;30(11):1745-59. doi: 10.1097/QAD.0000000000001104.
6
Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.2017-2021 年中国上海 HIV-1 感染者治疗前耐药性的流行和传播。
Virulence. 2024 Dec;15(1):2373105. doi: 10.1080/21505594.2024.2373105. Epub 2024 Jun 27.
7
HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study.在扩大艾滋病毒抗逆转录病毒治疗规模下的艾滋病毒传播和相关因素:基于人群的纵向分子网络研究。
Virol J. 2023 Dec 4;20(1):289. doi: 10.1186/s12985-023-02246-1.
8
No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naïve HIV Patients.在接受抗反转录病毒治疗的 HIV 患者中,注射吸毒者和非注射吸毒者的传播耐药率无差异:一项横断面研究。
Intervirology. 2018;61(6):281-291. doi: 10.1159/000499367. Epub 2019 Apr 24.
9
Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.中国广西地区抗逆转录病毒治疗失败的艾滋病病毒/获得性免疫缺陷综合征患者的耐药性和遗传传播网络的流行情况。
AIDS Res Hum Retroviruses. 2022 Oct;38(10):822-830. doi: 10.1089/AID.2021.0181. Epub 2022 Oct 5.
10
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.在斯威士兰、莱索托、马拉维、赞比亚和津巴布韦,接受抗逆转录病毒疗法的艾滋病毒阳性成年人中病毒载量未受抑制的流行情况及其相关因素(2015 年至 2017 年):基于人群的全国代表性调查结果。
J Int AIDS Soc. 2020 Nov;23(11):e25631. doi: 10.1002/jia2.25631.

引用本文的文献

1
The Peptide PROTAC Modality: A New Strategy for Drug Discovery.肽类PROTAC技术:药物发现的新策略。
MedComm (2020). 2025 Mar 24;6(4):e70133. doi: 10.1002/mco2.70133. eCollection 2025 Apr.